In trading today, Arch Biopartners Inc opened at $1.83 and closed at $1.75. Intraday prices ranged from $1.73 to $1.83.

Shares dipped -2.23% from the previous day's close of $1.79.

Today across North America, the TSX Composite closed -1.35% at 21714.54, the S&P 500 closed -1.57% at 5035.69, the Dow Jones Industrial Average closed -1.49% at 37815.92 and the Nasdaq Composite closed -2.04% at 15657.82.

Arch Biopartners Inc traded under ARCH on the Toronto Venture Exchange (TSX-V).

Trading volume was 23,730 on 74 total trades, with an average volume of 33,271 in the last five days.

Trading across the entire TSX-V saw 3,401 price advancers against 1,804 declines and 97 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, the shares have shrunken -15.46 percent in the last year, while in 2024, they have advanced 18.24%.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $112.51 million on a float of 62,856 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Arch Biopartners Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..